Topics

Companies Related to "Silencing Genes Cellular Protein Factories Amplifies Production http" [Most Relevant Company Matches] RSS

02:26 EDT 16th September 2019 | BioPortfolio

Here are the most relevant search results for "Silencing Genes Cellular Protein Factories Amplifies Production http" found in our extensive corporate database of over 50,000 company records.

Showing "Silencing Genes Cellular Protein Factories Amplifies Production http" Companies 1–25 of 4,700+

Extremely Relevant

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism pr...


Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism pr...

UniTargetingResearch

UniTargetingResearch AS (UTR) is dedicated to the development and commercialisation of novel technologies for the improved production of mammalian proteins, especially those which are therapeutically important. The company's foundation is based upon over 10 years of University research into protein secretion and untranslated regions of mRNA.Formed in 2001, the R&D focus has been on exploring uniqu...


Relevant

Confirmant Limited

Formed in June 2001, Confirmant is a joint venture between OGS and Marconi. It was conceived to develop, commercialise and market the output from OGS high throughput proteomics process.The first product resulting from this, the Protein Atlas, is due for commercial release Q3/4 2002. The Protein Atlas is a database of experimentally derived gene sequences mapped onto the human genome from the prote...

Agrisoma Biosciences Inc

Agrisoma Biosciences Inc. (“Agrisoma”) is a private biotechnology company committed to providing innovative products and technology solutions for sustainable agriculture, and improved human and animal health. Agrisoma is applying its proprietary technology for the development of value enhanced crops with higher yield, quality and commercial value, as well as the efficient production of indust...

Myriad Genetics

Myriad Genetics, Inc. is a leader in the discovery of major common human disease genes and their related pathways. TheCompany utilizes analyses of extensive family histories and genetic material, as well as a number of proprietary technologies, to identify inherited gene mutations which increase the risk to individuals of developing these diseases.The Company has also developed ProNet(TM), a propr...

H-Invitational Database

H-Invitational Database (H-InvDB) is an integrated database of human genes and transcripts. By extensive analyses of all human transcripts, we provide curated annotations of human genes and transcripts that include gene structures, alternative splicing isoforms, non-coding functional RNAs, protein functions, functional domains, sub-cellular localizations, metabolic pathways, protein 3D structure, ...

Hyseq Incorporated

Hyseq, Inc. is a biopharmaceutical company with a growing pipeline of product candidates in its genomics-based HyProfileportfolio. The primary product candidates are expressed proteins of novel rare genes discovered through applications of the Company's proprietary HyX platform in conjunction with work performed by its Functional Genomics, Protein Purification and Bioinformatics Groups. The Compan...

PROTEOGENIX SA

Proteogenix: Antibodies, Proteins, Peptides and Genes Proteogenix offers a large choice of custom services including polyclonal and monoclonal antibody development, recombinant protein production and purification, gene synthesis and peptide synthesis. Ascites production, antibody conjugation and fragmentation, western-blot and ELISA are also supplied.Commercial antibodies and proteins, Elisa kit...

Transkaryotic Therapies Incorporated RKT

Founded in 1988, Transkaryotic Therapies, Inc. (TKT) is a leading biopharmaceutical company in the production and delivery of protein therapies. TKT develops, and intends to commercialize, protein products for rare and common diseases. Through its three development platforms Niche Protein® products, Gene-Activated® proteins, and Gene Therapy, TKT currently has products in clinical development fo...

Delphi Genetics

Founded at the end of 2001, Delphi Genetics develops more effective products and technologies for genetic engineering and for protein expression in bacteria by using its unique expertise in the field of plasmid stabilisation systems. Delphi Genetics’ patented Staby® technology increases the recombinant protein production output without the u...

Quark Biotech, Inc.

Quark Biotech, Inc., is a biopharmaceutical company headquartered in the U.S., focused on the development of drugs based in its proprietary target genes.Quark has developed a broad technology portfolio covering fundamental drug discovery techniques as well as numerous specific disease targets. Through innovative combinations of gene silencing and DNA microarray technology, Quark has pioneered and ...

Proteinlounge

Protein Lounge is a leader in the field of system biology. We have developed many interactive web-based databases and software to help the life-scientists understand the complexity of systems biology. Systems biology efforts focus on understanding cellular networks, protein interactions involved in cell signaling, mechanisms of cell survival and apoptosis leading to development or identification o...

Pierce Biotechnology, Inc.

Pierce Biotechnology, a unit of the Fisher Biosciences group, is one of the first companies researchers turn to when they're conducting protein-studies and related research. Now that the human genome project is completed, researchers are focusing their efforts on the proteins encoded by the mapped genes. Pierce reagents and kits for protein purification, protein detection and quantitation, protein...

ZymoGenetics

For more than 25 years, ZymoGenetics has focused on the discovery, development, and commercialization of therapeutic proteins. Thanks to a robust discovery program, promising drug pipeline and strong development capabilities, ZymoGenetics is an emerging leader among biotherapeutic companies. ZymoGenetics is: Dedicated to the development of protein drugs. We are committed to developing protein dru...

LONGCOM ENTERPRICES

Longcom is an enterprise specially engaged in the production and supply of chemicals, pharmaceuticals, food and feed additives. Longcom has strengthened its close cooperation with the factories concerned in the forms of equity participation, joint operation and agency by agreement and has gradually formed a batch of the production bases of its own

Protein Bank

We produce active recombinant proteins as research reagents in mammalian hosts, provide quick drug target validation using high throughput mammalian technologies, and generate production cell lines from therapeutic protein production industry, receptorbodies peptibodies and antibodies.

PERCIVIA LLC

PERCIVIA LLC develops recombinant therapeutic proteins using the PER.C6® human cell line, with a focus on bio-better and bio-similar projects. PERCIVIA has developed a highly efficient protein production platform based on the PER.C6®cell line for the production of human therapeutic proteins with native human characteristics, at extremely high yields....

Chromos Molecular Systems Incorporated

Chromos Molecular Systems Inc. (“CHROMOS”; TSE: CHR) is a public Canadian biotechnology company leading the development of innovative therapies using a proprietary gene delivery and expression system for the production of therapeutic proteins and cell-mediated gene therapies to treat disease. Chromos is achieving this objective with a unique mammalian chromosome technology platform from which ...

Scarab Genomics, LLC

Scarab Genomics, a Madison, Wisconsin based biotechnology company, was established in 2002 to commercialize the Clean Genome® Multiple Deletion Series (MDS) E. coli that resulted from Dr. Fred Blattner’s first sequencing of E. coli at the University of Wisconsin. Scarab Genomics licensed the patented reduced genome technology from the Wisconsin Alu...

Message Pharmaceuticals Incorporated

MESSAGE PHARMACEUTICALS, INC. is an emerging biotechnology company dedicated to developing novel and proprietary screening assays for discovering new drugs. Currently, most drugs act by binding to specific sequences and structures within a target protein, such as a receptor or enzyme, and altering the protein's activity or function. MESSAGE's technology will allow for the identification of drugs...

Alnylam Biotherapeutics

RNAi (RNA interference) is a natural cellular process of gene silencing that represents one of the most promising and rapidly advancing frontiers in biology and drug development today. Its discovery has been heralded as “a major scientific breakthrough that happens once every decade or so,” and was recognized with the award of the 2006 Nobel Prize for Physiology or Medicine. By harnessi...

Sierra Sciences, Inc

Sierra Sciences, Inc. (SSI) is a biotech research company located in Reno, Nevada. Our mission is to discover a medicine to prevent and/or reverse cellular senescence (the phenomenon where cells lose the ability to divide).We believe that cellular senescence is an underlying cause of many conditions in cells which are related to the diseases of human aging, including aging itself. SSI was founded ...

Human Genome Sciences Incorporated

Human Genome Sciences, Inc. is engaged in the research and development of novel, proprietary pharmaceutical and diagnostic products based on the discovery and understanding of the medical utility of genes. Using automated, high-throughput gene sequencing technology, the Company has generated a very large collection of partial human gene sequences, which the Company believes correspond to most of t...

ORPEGEN Pharma

ORPEGEN Pharma is a contract manufacturer for active biopharmaceutical ingredients (bio APIs) such as proteins and peptides using know-how in biotechnological recombinant protein production as well as in peptide chemistry. We are located in Heidelberg, the hot spot of life sciences in Germany.Upon our client's demand it is ORPEGEN Pharma's competence to transform know-how from workbench into proce...


More From BioPortfolio on "Silencing Genes Cellular Protein Factories Amplifies Production http"

Quick Search

Corporate Database Quicklinks